PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 46: Articles 22501-23000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. [Administrative innovations in the family planning program of the Instituto Mexicano del Seguro Social: case study. [Innovaciones administrativas del programa de planificacion familiar del Instituto Mexicano del Seguro Social. Estudio de caso.]
  2. Adolescence: a contraceptive risk factor.
  3. The adolescent and availability of family planning services. FPAI - WHO Survey.
  4. Adolescent autonomy and minors' legal rights: contraception and abortion.
  5. Adolescent contraceptive behavior: influences and implications.
  6. Adolescent contraceptive decision-making.
  7. Adolescent contraceptive use: the impact of family support systems.
  8. Adolescent development and its effects on sexual and contraceptive behavior: development and evaluation of a training design for health professionals.
  9. Adolescent fertility and family planning: a review of selected research studies.
  10. The adolescent girl and contraception. Notes on the psychodynamics of pregnancy and motherhood desires (author's transl) [L'adolescente et la contraception. Reflexions sur la psychodynamique des desirs de grossesse et de maternite.]
  11. Adolescent sexual decision-making: contraception, pregnancy, abortion, motherhood.
  12. Adolescent sexuality and its challenges to the family planning movement: an Asian perspective.
  13. Adolescent sexuality, contraceptive and fertility decisions.
  14. Adolescents' use of a hospital-based contraceptive program.
  15. The search for male contraception. Men are different.
  16. Second Asian Regional Workshop on Injectable Contraceptives.
  17. Second contraceptive prevalence survey Colombia 1980: general results.
  18. The second-class partner: the male role in family-planning decisions.
  19. Secondary hyperparathyroidism caused by oral contraceptives.
  20. Secure contraception (voluntary sterilization) in Indonesia.
  21. Selection of family planning and health interventions for CBD projects.
  22. Selection of services for family planning and health in a household distribution project PRODEF.
  23. Seminar: Population Policy in Senegal: the Woman's Viewpoint and the Legal Implications, Dakar 15 - 18 November 1982. Volume 2. Women's attitude toward contraception and fertility. [Seminaire: Politique de Population au Senegal, le Point de Vue des Femmes et les Implications Juridiques, Dakar, 15 - 18 Novembre 1982. Tome II. Attitude des femmes face a la contraception et a la fecondite.]
  24. Sensitivity changes of the pituitary during administration of a triphasic oral contraceptive.
  25. Sequential contraceptive pills in the immediate postabortion period. [Traitement sequential contraceptif dans les suites immediates de l'I.V.G.]
  26. Serial detection of plasma-factor XIII levels during the ovulatory cycle and estroprogestative contraception.
  27. Serum glucose phosphate isomerase and ornithine carbamoyltransferase activities are increased in women taking contraceptive steroids.
  28. Serum protein binding of phenytoin in women: effect of pregnancy and oral contraceptives.
  29. Serum vitamin A, carotene and cholesterol levels in Nigerian women using various types of contraceptives.
  30. Sex education outreach from a family planning agency.
  31. Sex guilt and the use of contraception among unmarried women.
  32. Sex, sex guilt, and contraceptive use.
  33. Sexual activity and contraception patterns among young people in two communities in Finnmark County (author's transl) [Hammerfest-undersokinga. Seksualaktivitet og prevensjonsvanar blant ungdom i to kommunar i Finnmark.]
  34. Sexual and contraceptive behavior of adolescent girls. [Zum Sexual-und Kontrazeptionsverhalten minderjahriger Madchen.]
  35. Sexual and contraceptive behavior on a college campus: a five-year follow-up.
  36. Sexual behavior, contraception use and parenthood among urban black adolescent males.
  37. Sexual relationships and contraception. Evolution of their social significance. [Relations sexuelles et contraception. Evolution de leur signification sociale.]
  38. Sexuality, contraception, and pregnancy in patients with cyanotic congenital heart disease.
  39. Integrated family planning/parasite control project: a different approach to community health problems.
  40. Integrated maternal-child health and family planning services.
  41. Integrated project of family planning and parasite control on Oeiras.
  42. An integrated service--the role of the gynaecologist in family planning. A personal view.
  43. Integrated social services delivery system: Menoufia. Interim progress report on research component and family planning and health interventions, September 1, 1980-February 28,1982.
  44. Integrating family planning with health services--does it help?
  45. Integrating family planning with health services: does it help?
  46. Integrating family planning with other social services.
  47. Integration and family planning programme performance: an interpretive summary of research projects in Malaysia and the Republic of Korea on the determinants and impact of integration in family planning programmes.
  48. Intentions to use family planning and the unmet need for family planning in Nepal.
  49. Inter-country seminar on incentives for family planning/family welfare in industrial sector, Puncak (Indonesia) 5-9 October 1982: report and background paper.
  50. Interactions between antibiotics and oral contraceptives [letter]
  51. Interactions of contraceptive use and lactation.
  52. An interim report on the development of a family planning mobile exhibit for the Egyptian State Information Service.
  53. International Planned Parenthood Federation.
  54. Interrelationships between family planning, nutrition and parasite control.
  55. The intra-uterine contraceptive device--an attempt to prevent pain and expulsion with zomepirac sodium [letter]
  56. Intrahepatic cholestasis caused by oral contraceptives.
  57. Intrauterine contraception (author's trans) [La contraception par dispositif intra-uterin.]
  58. Intrauterine contraception, risk, indications, trends (author's transl) [Intrauterine Kontrazeption, Risiken, Indikationen, Trends.]
  59. Intrauterine contraception.
  60. Intrauterine contraceptive device: vaginal cytology, pathologic changes and their clinical implications.
  61. Intrauterine contraceptive devices for diabetic women [letter]
  62. Intrauterine contraceptive devices for diabetics [letter]
  63. Intrauterine contraceptive devices for diabetics [letter]
  64. Intrauterine contraceptive devices. Vaginal cytology, pathologic changes and clinical implications.
  65. An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia.
  66. An introduction to Contraceptive Prevalence Surveys and an illustrative analysis of data from countries in the ESCAP region.
  67. Inventory of selected local family planning programme experiences in countries of the ESCAP region. Vol. 4.
  68. The relationship of family planning to development.
  69. The relationship of static muscle function to use of oral contraceptives.
  70. The relationships of selected variables to the use/nonuse of contraceptives among undergraduate college and university students.
  71. The relative importance of family planning and development for fertility reduction: critique of research and development of theory.
  72. Relative weight, smoking and contraceptive pills: interrelations to blood pressure in students.
  73. Release of contraceptive progestogens from biodegradable systems.
  74. Religiosity, sexual behavior, and contraceptive use of college females.
  75. Removing barriers to adolescent contraceptive use by vigorous follow-up.
  76. Reply to Layde and Ory [concerning oral contraceptives, smoking and cardiovascular disease]
  77. Reply to Newman, Giles and Correy letter concerning multiple pregnancies and fetal abnormalities and oral contraceptive usage] [letter.
  78. Reply [to letter of Evrard concerning protection against endometrial carcinoma by combination-product oral contraceptives] [letter]
  79. Reply [to letter of I.H. Stockley concerning tetracycline and oral contraceptives] [letter]
  80. Report from an international symposium about advantages and risks of oral contraceptives. Amsterdam, March 1982. [Rapport fran ett internatiellt syposium om fordelar och risker med p-piller. Amsterdam mars 1982.]
  81. Report of the Advisory Group on Contraceptive Development Research.
  82. Report of the evaluation of Botswana's national maternal/child health and family planning programme and UNFPA assistance to the programme.
  83. Report of the Second Expert Group Meeting on Methods of Measuring the Impact of Family Planning Programmes on Fertility.
  84. Report on a consultancy to develop a model family planning clinic and program.
  85. A report on activities to develop IEC materials and to update lists of recommended supplies and equipment for the Family Planning Association of Morocco.
  86. Report on population and family planning activities.
  87. Report on the evaluation of the National Family Planning Program focussing on sterilization in 1980.
  88. Report on the evaluation of UNFPA assistance to the Swaziland family planning programme.
  89. Report. Results of evaluation of family planning information dissemination activities undertaken by Guatemala's Pro-Bienestar de la Familia's [APROFAM] Information, Education and Communication [IEC] Program during 1979-1981.
  90. The reproductive pharmacology and contraceptive application of LH-RH and its analogues.
  91. Research activities in the field of oral contraceptives in the People's Republic of China.
  92. Research in family planning clinics.
  93. Research in family planning: 1.
  94. Research in family planning: 2.
  95. Resistance to contraception revealed by clinical interview in therapeutic abortion requests (author's transl) [Mise en evidence des resistances a la contraception par l'entretien clinique dans les demandes d'IVG.]
  96. Results of longitudinal study on the psychological acceptance of contraception with Multiload Cu 250. [Resultate einer Langsschnitt-Studie uber die psychische Verarbeitung der Kontrazeption mit Multiload Cu 250.]
  97. The results of the Egyptian Contraceptive Prevalence Survey in rural Egypt, 1980.
  98. Retail costs of contraceptive supplies [memorandum]
  99. Reticence concerning male contraception (editorial) [Les reticences a la contraception masculine.]
  100. 'For the public good': early birth control clinics in Canada.
  101. 'Tout moun ap fe planing anvan lane 2000'--(Everyone to practice family planning by the year 2000)
  102. 1 year's catamnesis of a longitudinal study on the psychological acceptance of contraception with Multiload Cu 250. Final report. [1-Jahres-Katamnese einer Langsschnittstudie uber die psychische Verarbeitung der Kontrazeption mit Multiload Cu 250. (Schlussbericht)]
  103. The 15-year-old mother] Contraception in adolescents. [Mit 15 Mutter] Kontrazeption bei Jugendlichen]]
  104. Advances in contraceptive technology.
  105. Advantages and risks of hormonal contraception (author's transl) [Vorteile und Risiken der hormonalen Kontrazeption.]
  106. Advertising agencies and contraceptive social marketing programs.
  107. Agricultural production responsibility system and the work of family planning in the rural area.
  108. Airing contraceptive commercials.
  109. Alteration in blood pressures associated with combined alcohol and oral contraceptive use--the Lipid Research Clinics Prevalence Study.
  110. Alternation, or the best approach to contraception. [L'alternance ou la bonne politique en contraception.]
  111. Alternative measurements of unmet need for contraception in World Fertility Surveys of developing countries.
  112. American women and birth control in modern history.
  113. Analysis of a peer contraception education program based on the health belief model.
  114. An analysis of access to contraceptive care in western Pennsylvania.
  115. Analysis of the continuity of use of contraceptive methods in Mexico during the period 1974-1979. [Analisis de la continuidad en el uso de metodos anticonceptivos en Mexico en el periodo 1974-1979.]
  116. Annual report of the Family Planning Association of Bangladesh for 1981.
  117. Anthropology and family planning: culturally appropriate intervention in a Mexican community.
  118. Antibiotics and oral contraceptive failure: an update.
  119. Antihelminthic therapy in community based family planning and health projects.
  120. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
  121. Appendiceal perforation by intrauterine contraceptive device [letter]
  122. Application of methods of measuring the impact of family planning programmes on fertility: the case of Hong Kong.
  123. Application of methods of measuring the impact of family planning programmes on fertility: the case of Malaysia.
  124. Application of methods of measuring the impact of family planning programmes on fertility: the case of Mauritius.
  125. Application of methods of measuring the impact of family planning programmes on fertility: the case of Mexico.
  126. Application of methods of measuring the impact of family planning programmes on fertility: the case of Thailand.
  127. Application of methods of measuring the impact of family planning programmes on fertility: the case of the Republic of Korea.
  128. An approach to family planning for Indochinese refugee women.
  129. Approaches to integrated programs: health, family planning and development: a strategy workshop for private voluntary organizations, April 12-14 1982, Washington, D.C.
  130. Are there long-term health and behavioural consequences of exposure to hormonal contraceptives in breast-milk?
  131. Arterial thrombosis in oral contraceptive users [editorial]
  132. Asian family planning programs: performance and its determinants. Interim report: 9/81/-7/82. AID Research Contract Project No. 932-0632. Center for Population Planning University of Michigan.
  133. Assessment of family planning needs in Bangladesh.
  134. Association for Population/Family Planning Libraries and Information Centers-International.
  135. At what age is contraception no longer necessary. [Op welke leeftijd is contraceptie niet meer nodig?]
  136. Atherosclerosis and oral contraceptive use. Serum from oral contraceptive users stimulates growth of arterial smooth muscle cells.
  137. An atlas of intrauterine contraception.
  138. Attendance for contraception and termination of pregnancy--a comparison of two practices.
  139. Attitude of the university student to contraceptive methods. [Actidud del estudiante universitario hacia los metodos anticonceptivos.]
  140. Attitude of women toward family planning in the poor environment of a Dakar suburb. [Attitude des femmes en milieu populaire de la banlieue dakaroise face au planning familial.]
  141. Attitudes of Chinese women towards sexuality and birth control.
  142. Attitudes regarding family planning [letter]
  143. Australian experience with hormonal contraception over two decades.
  144. An autopsy case of primary hepatoma associated with an oral contraceptive.
  145. Barrier and chemical contraceptives.
  146. Barrier contraceptives and toxic shock syndrome [letter]
  147. Barrier contraceptives in the prevention of cervical cancer.
  148. Barrier methods of contraception. [Metodos anticonceptivos de barrera.]
  149. Basic data on visits to family planning services sites.
  150. Basic data on women who use family planning clinics: United States, 1980.
  151. Basic information on population and family planning program.
  152. The beginning of hormonal contraception and Munchener Medizinische Wochenschrift (author's transl) [Die Anfange der hormonalen Knotrazeption und die Munchener Medizinishce Wochenschrift.]
  153. Behavioral intention of the Thais in family planning and contraceptive practice.
  154. Benign hepatic tumor and oral contraception (author's transl)
  155. Benign liver tumors and oral contraceptives.
  156. Benign liver tumors and their relation to use of oral contraceptives. [Les tumeurs benignes du foie et leurs relations avec la prise de contraceptifs oraux.]
  157. The best of both worlds. Applying self-sustaining concepts in government subsidized family planning programs: a how-to-do-it manual for program managers.
  158. The biggest contraceptive in the world.
  159. Biliary disease in young women and its association with pregnancy or oral contraceptives.
  160. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
  161. Biodegradable microcapsules for contraceptive steroids.
  162. The biological basis for the contraceptive effects of breast feeding.
  163. Biology--contraception--adolescence. From the physiology of puberty to the possible physiopathology of contraception in the formative years Pt. 1 (author's transl) [Biologie--contraception--adolescence. De la physiologie de la puberte a la physio-pathologie eventuelle de la contraception au cours de la formation.]
  164. Birth control and abortion in the cardiac patient.
  165. Birth control and the population question in England, 1877-1930.
  166. Birth control clinics in schools.

     

  167. Birth control movement.
  168. Birth control pills and pancreatitis.
  169. Birth control trends and preference for male children in Jordan and Sudan.
  170. Birth control: a view from a Chinese village.
  171. Birth-control in the west in the thirteenth and early fourteenth centuries.
  172. Births averted in Tunisia by contraception in recent years.
  173. Blood pressure and contraceptive use.
  174. Bolivia: industrial settings and family planning promotion and services. Project description.
  175. Bowel perforation by an intra-uterine contraceptive device [letter]
  176. Bowel perforation by the Multiload Cu 250 intra-uterine contraceptive device. A case report.
  177. Breast-feeding and family planning: a review of the relationships between breast-feeding and family planning.
  178. Breastfeeding in Thailand: data from the 1981 contraceptive prevalence survey.
  179. British embrace a gentler postcoital contraceptive.
  180. Budd-Chiari disease caused by long-term administration of oral contraceptives. [Budd-Chiari-betegseg tartos oralis fogamzasgatlo-szedes kapcsan.]
  181. The Calabar Rural Maternal and Child Health/Family Planning Project: evaluation and research component.
  182. Can adolescents be motivated to learn about birth control?
  183. A Canadian multicentre triphasic oral contraceptive clinical trial.
  184. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
  185. Cardiovascular effects and progestins in oral contraceptives.
  186. Careers: family planning: fundamental to care.
  187. Cases of neuro-ophthalmological complications after the use of oral contraceptive agents (author's transl) [Przypadki powiklan neurookulistycznych po stosowaniu doustnych srodkow antykoncepcyjnych.]
  188. The cells from intrauterine contraceptive devices with special reference to the occurrence of mast cells.
  189. The cervical cap: a barrier contraceptive.
  190. The cervical cap: an alternate barrier contraceptive method.
  191. Change of fertility and contraceptive intentions in Hajdu County between 1977-1979. Early findings of maternity care monitoring (MCM) in Debrecen (author's transl) [A szulesi es fogamzasgatlasi szandek valtozasa 1977-1979 kozott Hajdu megyeben. (A nemzetkozi szuleszeti rendtaktas Debreceni eredmenyei)]
  192. Changes in contraceptive use prevalence and knowledge in three rural Profamilia CBD service areas of Colombia: policy implications.
  193. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
  194. Changing concepts and data needs as methodology of evaluating family planning programmes develops.
  195. Changing pattern of cervical intraepithelial neoplasia seen in a family planning clinic [letter]
  196. Characteristics of new family planning users, 1974--1977--1981. [Caracteristicas de las usuarias nuevas de planificacion familiar 1974--1977--1981.]
  197. Chemical cystourethritis: the errant contraceptive.
  198. The chemical studies of steroid contraceptives in China.
  199. Chemical synthesis of new long-acting contraceptives.
  200. Child mortality and contraception usage: a study of rural acceptors in Nigeria.
  201. Child mortality and lactation contraception in Mexico.
  202. The choice for contraceptive surgery: man or woman.
  203. Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl) [Ikterus durch D-Penizillamin und hormonale Kontrazeption bei progressiver Sklerodermie.]
  204. The chromosomal effects of the oral contraceptive.
  205. Chronic intestinal ischemia associated with oral contraceptive use.
  206. Clinical correlations between contraceptives and cytopathies. [Indagine sul rapporto tra metodi contraccettivi e cistopatie.]
  207. Clinical evaluation of 1,668 cycles of oral triphasic contraception (Trigynon): multicenter Belgian study. [Evaluation clinique de 1.668 cycles sous contraception orale triphasique (Trigynon). Etude Belge multicentrique.]
  208. Clinical evaluation of the Multiload 250 Cu-IUD in a Malaysian family planning clinic.
  209. Clinical experience and results with a new chemical vaginal contraceptive.
  210. Clinical experience with triphasic oral contraceptives (Trigynon) in six hundred cycles.
  211. The clinical pharmacology of oral contraceptive steroids.
  212. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
  213. Coercion in a soft state: the family planning program of India. Part 1: the myth of voluntarism.
  214. Colombia's integrated project--family planning and parasite control: a steady partnership.
  215. Comment on "Multiple Pregnancy and Fetal Abnormalities in Association with Oral Contraceptive Usage" by D.C. Macourt] [letter.
  216. Commentary [on contraceptive method and future fertility]
  217. Comments on proposed physician and patient oral contraceptive labeling.
  218. Comments on the action of oral contraceptives (author's transl) [K problematike vplyvu peroralnych kontraceptiv na intravazalnukoagulaciu.]
  219. Commercial marketing of contraceptives in Malaysia: the nonprogram user segment.
  220. Communicating family planning to Egypt: a report on the State Information Service Communication Campaign to Promote Contraceptive Adoption, 1980-1982.
  221. Communication and cognitive, attitudinal and behavioral change in family planning.
  222. Communication and cognitive, attitudinal and behavioral change in family planning. [La comunicacion y el cambio cognoscitivo, actitudinal y conductual en la planificacion familiar.]
  223. Communication and contraception in rural Uttar Pradesh.
  224. Communication patterns with respect to family planning among colored youth in Eersterust. [Kommunikasiepatrone ten opsigte van gesinsbeplanning by die jeugdige Kluerling in Eersterust.]
  225. Community characteristics and contraception in rural Costa Rica, 1982. [Caracteristicas de la comunidad y anticoncepcion en el area rural de Costa Rica, 1982.]
  226. Community forum. 2. Contraception.
  227. Community participation in family planning: issues and examples.
  228. Community participation in family planning: role of non-governmental organizations.
  229. Community participation in family planning: some issues.
  230. Community-based delivery (CBD) of low-cost family planning and maternal and child health services in rural Nigeria.
  231. Community-based distribution of low cost family planning and maternal and child health services in rural Nigeria (pilot project)
  232. Comparative analysis of fertility, breastfeeding and contraception: a dynamic model.
  233. Comparative data from contraceptive prevalence surveys: knowledge, use, and availability of family planning in eight countries.
  234. Comparative investigation of oral contraceptives using randomized, prospective protocols.
  235. Comparative randomized double-blind study of high dosage ethinyl estradiol versus ethinyl estradiol and norgestrel combination in postcoital contraception.
  236. A comparison of response to adolescent-oriented and traditional contraceptive programs.
  237. Comprehensive fertility awareness and natural family planning (teacher training manual)
  238. Conference on Voluntary Surgical Contraception.
  239. Conflictual contraception in the adolescent. Psychodynamic hypotheses on the desires for pregnancy and maternity. [Contraception conflictuelle chez l'adolescente. Hypotheses psychodynamiques sur les desirs de grossesse et de maternite.]
  240. Congenital abnormalities in the offspring of women who used oral and other contraceptives around the time of conception.
  241. Continuation of injectable contraceptives in Thailand.
  242. Continued use of contraception in Mexico during the period 1974-1979.
  243. Contraception (part 1): condoms, rhythm, spermicidal agents, diaphragms, intrauterine devices.
  244. Contraception (part 2): the pill.
  245. Contraception and abortion in New Zealand: a review article.
  246. Contraception and community in Egypt: a preliminary evaluation of the population/development mix.
  247. Contraception and demography. [Contraception et demographie.]
  248. Contraception and its effect on the quality of prenatal care (author's transl) [Kontracepcija i njen utjecaj na kvalitetu nadzora trudnoce.]
  249. Contraception and migration: family planning in the North African and Portuguese migrant setting. [Contraception et migration: planification familiale en milieu migrant Nord-Africain et Portuguais.]
  250. Contraception and multiple sclerosis (author's transl) [Kontrazaption und Multiple Sklerose.]
  251. Contraception and sexuality. [Contraception et sexualite.]
  252. Contraception by IUD. Pt. 1. Different types of IUDs and mode of action. [Contraception par sterilet. 1re partie: Differents types de sterilets et mode d'action.]
  253. Contraception by IUD. Pt. 2. Practical applications. [Contraception par sterilet. 2e partie: applications pratiques.]
  254. Contraception by post-coital IUD insertion. [Contraception par D.I.U. post-coital.]
  255. Contraception by progestins. [Contraception par progestatifs.]
  256. Contraception consultation. Choice of contraception method. [La consultation de contraception. Choix du moyen contraceptif.]
  257. Contraception during lactation.
  258. Contraception during the post-partum period and while lactating: effects on the woman's health.
  259. Contraception following second trimester abortion.
  260. Contraception for adolescents (author's transl) [Kontrazeption bei Jugendlichen.]
  261. Contraception for intellectually handicapped people: legal and ethical issues.
  262. Contraception for middle aged women.
  263. Contraception in adolescence.
  264. Contraception in adolescence. [La contraception a l'adolescence.]
  265. Contraception in adolescents (author's transl) [Contraception chez l'adolescente.]
  266. Contraception in adolescents according to recent scientific understanding. [Kontrazeption bei Jugendlichen entsprechend den neueren wissenschaftlichen Erkenntnissen.]
  267. Contraception in diabetics. [letter]
  268. Contraception in ethnic minority groups in Bedford.
  269. Contraception in North-African immigrants (author's transl) [Contraception chez la nord-africaine immigree.]
  270. Contraception in teenagers (author's transl) [Problematique de la contraception chez les adolescentes.]
  271. Contraception in the Antilles. [Anticonceptie op de Antillen.]
  272. Contraception in the perimenopausal years.
  273. Contraception in the perimenopause.
  274. Contraception in the press. [La contraception dans la press.]
  275. Contraception in women with renal failure (author's transl) [La contraception chez les femmes en insuffisance renale.]
  276. A contraception manual. [Manual de anticoncepcion.]
  277. Contraception with discontinuous treatment with buserelin and gestagen induced bleeding.
  278. Contraception, pregnancy and mode of delivery in patients with congenital or acquired heart abnormalities. [Antikonzeption, Schwangerschaft und Entbindungsmethoden bei angeborenen und erworbenen Vitien.]
  279. Contraception, pregnancy management and the clinic: opinions of 1271 puerperas in a large hospital on the northern border of Milan. [La contraccezione, l'assistenza alla gravidanza e il consultorio: l'opinione di 1271 puerpere di un grosso ospedale della periferia settentrionale di Milano.]
  280. Contraception, pregnancy management and the family planning clinic (findings on 410 puerperas in a Lombard hospital) [La contraccezione, l'assistenza alla gravidanza ed il consultorio (indagine su 410 puerpere di un ospedale lombardo)]
  281. Contraception: a political discussion. [Contraception: un debat politique.]
  282. Contraception: comparing the options.
  283. Contraception: yes, but at what cost? [La contraception: oui, mais a quel prix?]
  284. Contraceptive advertising [letter]
  285. Contraceptive advertising [reply to letter of Richard Mittleman] [letter]
  286. Contraceptive advertising.
  287. Contraceptive advice and assistance to a child under sixteen.
  288. Contraceptive availability and family limitation in Mexico and rural Korea.
  289. The contraceptive behavior of Jordanian couples.
  290. Contraceptive choice and maternal image.
  291. Contraceptive cover for rubella vaccination.
  292. Contraceptive crisis [letter]
  293. Contraceptive decision making among adolescent girls.
  294. Contraceptive distribution in rural Haiti: some lessons learned.
  295. Contraceptive effect of breast feeding [editorial]
  296. Contraceptive effect of medroxyprogesterone acetate and estradiol cypionate association, in monthly injections.
  297. Contraceptive effects of an agonistic LH-RH analog (Buserelin)
  298. Contraceptive manufacturing in India.
  299. Contraceptive method switching among American female adolescents, 1979.
  300. Contraceptive methods. 1. Overview.
  301. Contraceptive methods. 2. Oral contraceptives and intrauterine devices.
  302. Contraceptive of choice for disabled (handicapped) person.
  303. The contraceptive potential of antisperm antibodies.
  304. Contraceptive practice and community-based distribution program impact in northeast Brazil.
  305. Contraceptive practice in Bangladesh: a study of mediators and differentials.
  306. The contraceptive practice of one thousand abortion patients.
  307. Contraceptive preference of adolescents and contraceptive counseling (author's transl) [Kontrazeptionswunsche von Jugendlichen und die Funktion der Beratung.]
  308. Contraceptive Prevalence Survey, Egypt 1980: summary report.
  309. Contraceptive research on the value and cost of children.
  310. Contraceptive sheaths: a report on the supply in the United Kingdom of contraceptive sheaths.
  311. Contraceptive social marketing guidelines for project development.
  312. The contraceptive sponge. [Le tampon contraceptif.]
  313. Contraceptive steroids, age, and the cardiovascular system.
  314. Contraceptive subdermal implants.
  315. Contraceptive technology 1982-1983. 11th rev. ed.
  316. Contraceptive trend following M.T.P.
  317. Contraceptive usage and continuation in the family planning program of Mexico.
  318. Contraceptive use in Java-Bali: a multivariate analysis of the determinants of contraceptive use.
  319. Contraceptive use patterns, prior source, and pregnancy history of female family planning patients: United States, 1980.
  320. Contraceptive use. 1. Developing countries.
  321. Contraceptive use. 2. United States overview.
  322. Contraceptive use. 3. United States since 1970.
  323. Contraceptive vaccines.
  324. Contraceptive vaginal rings.
  325. Contraceptives and drug regulation: an international perspective.
  326. Contraceptives save lives.
  327. Control of birth.
  328. Control of human reproduction: contraception, sterilization, and induced abortion.
  329. Controlled clinical investigation of the depot contraceptive norethisterone oenanthate in the Philippines.
  330. Coping with contraception: a cognitive-behavioral approach to prevention of unwanted teenage pregnancy.
  331. Copper iontophoresis in male contraception.
  332. Correlates of husband-wife attitudes towards family planning in rural Ghana (West Africa)
  333. Correlates of social and health status with family planning performance in India.
  334. Cost-effectiveness of a community-based family planning program in Cheju, Korea.
  335. Cost-effectiveness of family planning interventions.
  336. Cost-effectiveness trends and comparisons among contraceptive social marketing programs.
  337. Cottonseed oil as a vaginal contraceptive.
  338. Cottonseed--a source of vaginal contraceptive (author's transl) [La graine de coton a l'origine d'une contraception vaginale.]
  339. Counseling grant evaluation. Planned Parenthood of Metropolitan Washington, June 1982.
  340. Counseling on contraception following interruption of pregnancy. Responsibility of the hospital gynecologist. Model of contraceptive counseling at Berlin Neukolln. [Kontrazeptionsberatung nach Schwangerschaftsabbruch. Eine Aufgabe des klinisch tatigen Frauenarztes Das Modell der Kontrazeptionsberatung an der Frauenklinik Berlin-Neukolln.]
  341. Counseling skills in family planning: participant's handbook.
  342. Counseling skills in family planning: trainer's handbook.
  343. Country paper: Indonesia. The role of the traditional birth attendants in the national family planning programme.
  344. Couple-directed contraceptive counseling.
  345. Critique of an article by F.M. Sturtevant entitled "Smoking, Oral contraceptives, and Thromboembolic Disease".
  346. Current concepts about usage, risks, and benefits of oral contraceptives.
  347. Current contraceptive practice in some Brazilian states. [Pratica contraceptiva atual em alguns estados Brasileros.]
  348. Current data on nonsurgical male contraception. [Donnees actuelles sur la contraception masculine non chirurgicale.]
  349. Current developments in hormonal contraception. [Nieuwe ontwikkelingen in de hormonale anticonceptie.]
  350. Current functioning and future priorities in family planning services delivery.
  351. Current problems with intrauterine contraception. [Aktuelle Problematik der intrauterinen Kontrazeption.]
  352. Current trends in female contraception (author's transl) [Tendences nouvelles de la contraception feminine.]
  353. Cyclical changes in olfactory and auditory sensitivity during the menstrual cycle: no attenuation by oral contraceptive medication.
  354. Deaths from contraceptive sterilization in Bangladesh: rates, causes, and prevention.
  355. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen.
  356. Defending effectiveness of family planning [letter]
  357. Delayed parenthood choice: impact and implications for family planning programs.
  358. The demand for family planning services in the Sudan.
  359. Demographic and social characteristics of family planning acceptors in Jordan.
  360. Demographic aspects of surgical contraception in Sri Lanka.
  361. Demographic evaluation of family planning programs.
  362. Demographic evaluation of progress and target of national family planning programme of India.
  363. The demographic impact of the Family Planning Health Services Project in Matlab, Bangladesh.
  364. Demographic transition and growth of family planning programme in Punjab.
  365. Demonstration of a spirocheticidal effect by chemical contraceptives on Treponema Pallidum.
  366. A demonstration research project for the operation of a counseling and family planning service. Final report: January, 1976-January, 1979.
  367. Dependable fertility control: hazards and barriers (author's transl) [Le controle responsable de la fecondite: aleas et obstacles a la contraception.]
  368. Depo-Provera contraceptive injections in quarterly administration during breast feeding period.
  369. Depo-Provera for contraception: information for Public board of Inquiry on Depo-Provera: responses to the Board's questions.
  370. Depo-Provera for contraception: information for United States Food and Drug Administration Public Board of Inquiry Hearing. Vol. 1. Responses to FDA questions.
  371. Depot medroxyprogesterone acetate: use as a contraceptive. Rev. ed.
  372. Desire for pregnancy, refusal of pregnancy, ambivalence in family planning. [Desir de grossesse--refus de grossesse ou les embuches du desir dans le planning familial.]
  373. Determinants of contraceptive use and choice of method in Peninsular Malaysia.
  374. Determinants of fertility and the demand for family planning: a review and assessment of studies and how they explain the Egyptian experience.
  375. The determinants of modern contraceptive use in Indonesia: analyses of the effect of program effort.
  376. The development of a curriculum guide in health education related to family planning for secondary school teachers in Nigeria.
  377. Development of a national plan for training in family planning (Yemen Arab Republic)
  378. Development of operations research proposals for two Brazilian family planning organizations: BEMFAM and CPAIMC.
  379. Development, implementation and evaluation of a videotaped program to train pharmacists and pharmacy students to conduct family planning consultations.
  380. Dialogue one. An overview of oral contraception.
  381. Dialogue three. Oral contraception and the teenager.
  382. Dialogue two. Safety and effectiveness of low-dose oral contraceptives.
  383. Differences in fertility and family planning practices by type of family.
  384. Differential performance of family planning delivery systems at the district level: an evaluation.
  385. Differential response by husbands and wives regarding contraceptive practice.
  386. Differentials in the use of more effective contraceptive methods: 1980 AFS.
  387. Directory of non-government organisations (NGOs) in family planning.
  388. Discontinuance of oral contraceptives [letter]
  389. Diseases of the lower abdomen due to intrauterine contraceptive device.
  390. Distribution and percentages of non-protein bound contraceptive steroids in human serum.
  391. The dream of love and the reality of contraception. Current adolescent sexual behavior and contraceptive methods (author's transl) [Von Liebe traumen--an Verhutung denken Jugendsexualitat und Kontrazeption heute.]
  392. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
  393. Dynamics of depotmedroxy progesterone acetate (DMPA) use effectiveness in the Matlab Family Planning Health Services Project.
  394. An economic analysis of Thailand's National Family Planning Program: evaluation of the past and planning for the future. Rev.
  395. The economic benefits of family planning.

     

  396. Editorial: contraception and sexuality among adolescents. [Editorial.]
  397. Education in family planning.
  398. Effect of chronic contraceptive oral steroids on theophylline disposition.
  399. Effect of combined oral contraceptives on glycosylated haemoglobin.
  400. Effect of contraceptive steroids on creatine kinase activity in serum [letter]
  401. Effect of dihydroxydibutylether (DHBE) on the suprasaturation of biliary cholesterol in women taking oral contraceptives.
  402. Effect of femigen used as a contraceptive on female sexuality. [Wplyw femigenu stosowanego w celach antykoncepcyjnych na seksualnosc kobiet.]
  403. Effect of hormonal contraceptives and IUD on duration of lactation and return of menstruation in lactating women.
  404. Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol) [Wirkung eines hormonalen Kontrazeptivum mit 0.05 mg Ethinylestradiol und 0.125 mg Desogestrel in normophasischer Einnahmefolge (Oviol)]
  405. The effect of intensification of the family planning programme on the quality and number of acceptors.
  406. Effect of low estrogen combination of oral contraceptive on metabolism of aspirin and phenylbutazone.
  407. The effect of marital dissolution on contraceptive protection.
  408. Effect of oral contraceptive agents on the periodontium. [Uticaj oralnih kontraceptivnih sredstava na parodoncijum.]
  409. The effect of oral contraceptives on coagulation and fibrinolytic parameters in the Chinese--a prospective study.
  410. Effect of oral contraceptives on dietary intakes and nutritional status.
  411. Effect of oral contraceptives on some biochemical aspects in bilharzial Egyptian females living in rural areas.
  412. Effect of oral contraceptives on the formation of cholesterol crystals in gallbladder bile. [Effecto de los anticonceptivos orales en la formacion de cristales de colesterol en la bilis vesicular.]
  413. Effect of oral contraceptives upon the metabolism of vitamin B6, folic acid, serum iron, glycemia, hemoglobin and hematocrit (author's trans) [Efeito das pilulas anticoncepcionais sobre o metabolismo da vitamina B6, acido folico, ferro serico, glicemia, hemoglobina e hematocrito.]
  414. Effect of supply source on oral contraceptive use in Mexico.
  415. The effect of various oral contraceptive combinations on premenstrual symptoms.
  416. Effect on blood pressure of changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
  417. Effective use of vaginal contraception--a method for the 1980s.
  418. The effectiveness of barrier methods of contraception with and without spermicide.
  419. The effectiveness of contraceptive programs for teenagers.
  420. Effectiveness of natural family planning methods.
  421. Effects of a triphasic and a biphasic oral contraceptive on various hemostatic parameters.
  422. The effects of ampicillin on oral contraceptive steroids in women.
  423. The effects of contraceptive methods on the quality and quantity of breast-milk.
  424. Effects of contraceptives on initiation and duration of lactation [draft]
  425. Effects of hormonal and nonhormonal contraceptives on human lactation and re-establishment of fertility.
  426. The effects of microcomputer assisted instruction on the contraceptive knowledge, attitudes, and behavior of college students.
  427. Effects of nutrition education on obesity and hypertension within a family planning clinic.
  428. Effects of oral contraceptive steroids on corneal curvature.
  429. Effects of oral contraceptives on the oral structures: a review.
  430. Effects of pregnancy, oral contraception, and binephrectomy, on human plasma "prorenin" and its activator(s)
  431. Effects of switching from higher-dose oral contraceptives to a triphasic preparation (Triquilar)
  432. Efficacy of different contraceptive methods.
  433. The Eighth Asian Parasite Control/Family Planning Conference: proceedings.
  434. The elimination of medieval birth control and the witch trials of modern times.
  435. Emphasizing ideological education, implementing birth control measures and carrying out family planning in an appropriate way.
  436. The establishment of a postcoital contraception service.
  437. Estimating potential contraceptive demand: an improved method of measurement.
  438. Estrogen potency of oral contraceptive is confusing.
  439. Estrogens in oral contraceptives: historical perspectives.
  440. Ethical considerations concerning adolescents consulting for contraceptive services.
  441. Ethics and contraception in adolescence. [Ethique et contraception a l'adolescence.]
  442. Ethnic differences in fertility and contraceptive use in Sri Lanka.
  443. Ethnic variation in adolescent use of a contraceptive service.
  444. Evaluation of a type of biomedicated IUD (model Copper 7 200) in a family planning clinic. [Avaliacao de um tipo de dispositivo intra-uterino biomedicado (modelo "7 de cobre 200") em uma clinica de planejamento familiar.]
  445. Evaluation of family planning communications in El Salvador.
  446. Evaluation of family planning program impact with computer models.
  447. Evaluation of integrated schemes and strategies in family planning/family welfare/family health programmes.
  448. Evaluation of the impact of family planning programmes on fertility: sources of variance.
  449. An evaluation of the impact of the Population and Development Program (PDP), based on data from the 1980 Contraceptive Prevalence Survey.
  450. Evaluation of the national family planning program, 1977 to 1982. [Evaluacion del programa nacional de planificacion familiar 1977-1982.]
  451. An evaluation of the population and family planning support project in Morocco.
  452. Evaluation report of UNFPA assistance to the National Family Planning Programme of Thailand: Project THA/76/PO1--expansion of family planning services and support to the infrastructure of the NFPP and Project THA/76/PO5--National Family Planning Communication Programme.
  453. Evaluative methodology of a family planning service. [Metodologia valutativa di un servizio di pianificazione familiare.]
  454. The expanded sterilization project, National Family Planning Program, Ministry of Public Health.
  455. Expansion of voluntary surgical contraception into rural, remote, and peripheral areas: report of an Expert Study Committee.
  456. The experience of carrying out the technical responsibility system in the birth control of Peng County, Sichuan Province.
  457. Experience with contraception in Quebec. [Pratiques de contraception au Quebec.]
  458. Experience with norethisterone 0.35 mg daily as an oral contraceptive.
  459. Experiences in integrated family planning programmes in the ESCAP region.
  460. Experiment with foaming intravaginal suppository shows good contraceptive effect and tolerance. [Forsok med skumbildande vagitorium visar pa god skyddseffekt och tolerans.]
  461. An explanatory model of contraceptive use among young single women.
  462. Factors affecting the association of oral contraceptives and ovarian cancer.
  463. Factors affecting the innovation process for contraceptive products.
  464. Factors associated with compliance to oral contraceptive use in an adolescent population.
  465. Factors influencing choice of contraceptive method among married fecund women who intend no additional births: health belief model and economic perspectives.
  466. Factors related to effective contraceptive use in adolescent women.
  467. Factors that determine the decision to accept surgical contraception.
  468. Facts about injectable contraceptives.
  469. Failure with the new triphasic oral contraceptive Logynon [letter]
  470. Failure with the new triphasic oral contraceptive Logynon [letter]
  471. Failure with the new triphasic oral contraceptive Logynon.
  472. Family planning -- some Catholic comments.
  473. Family planning activities and services in the Sudan.
  474. Family planning activities in Mexico.
  475. Family planning activities. [Las actividades de planificacion familiar.]
  476. Family planning activity in Thailand.
  477. Family planning aid in Sri Lanka.
  478. Family planning and contraception. [Familjeplanering och anticonception.]
  479. Family planning and family welfare.
  480. Family planning and health in rural Bangladesh.
  481. Family planning and illness [editorial]
  482. Family planning and increased fitness of the child to survive.
  483. Family planning and maternal-child health.
  484. Family planning and maternal-child health. [Planificacion familiar y salud materno infantil.]
  485. Family planning and population 1982. Communication and education catalogue.
  486. Family planning and sex education.
  487. Family planning and teenagers: the facts.
  488. Family planning and the health care team in the hospital setting. [Le planning familial et l'equipe soignante en milieu hospitalier.]
  489. Family planning and the pharmacist: the case for greater involvement.
  490. Family planning and voluntary organizations.
  491. The Family Planning Association: perspectives on sex education.
  492. Family planning clinics: cure or cause of teenage pregnancy?
  493. Family planning communication research possibilities in Indonesia.
  494. Family planning compendium. Mexico, 1982.
  495. The family planning component.
  496. Family planning components in community based distribution projects.
  497. Family planning education. [Educacion en planificacion familiar.]
  498. Family planning for developing countries.
  499. Family planning in a suburban development of Mexico City. [Planificacion familiar en una colonia marginada de la ciudad de Mexico.]
  500. Family planning in Europe and USA in the 1970s.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.